Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Profound Medical (PROF) Net Income towards Common Stockholders (2023 - 2025)

Historic Net Income towards Common Stockholders for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to -$8.0 million.

  • Profound Medical's Net Income towards Common Stockholders rose 1482.11% to -$8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$40.0 million, marking a year-over-year increase of 4410.9%. This contributed to the annual value of -$28.4 million for FY2024, which is 251.68% up from last year.
  • Per Profound Medical's latest filing, its Net Income towards Common Stockholders stood at -$8.0 million for Q3 2025, which was up 1482.11% from -$15.7 million recorded in Q2 2025.
  • In the past 5 years, Profound Medical's Net Income towards Common Stockholders ranged from a high of $7.3 million in Q2 2023 and a low of -$48.6 million during Q4 2023
  • Moreover, its 3-year median value for Net Income towards Common Stockholders was -$6.9 million (2024), whereas its average is -$8.4 million.
  • Examining YoY changes over the last 5 years, Profound Medical's Net Income towards Common Stockholders showed a top increase of 8856.28% in 2024 and a maximum decrease of 26941.03% in 2024.
  • Over the past 3 years, Profound Medical's Net Income towards Common Stockholders (Quarter) stood at -$48.6 million in 2023, then surged by 88.56% to -$5.6 million in 2024, then tumbled by 43.45% to -$8.0 million in 2025.
  • Its Net Income towards Common Stockholders was -$8.0 million in Q3 2025, compared to -$15.7 million in Q2 2025 and -$10.7 million in Q1 2025.